, Tracking Stock Market Picks
Enter Symbol:
Adamas Pharmaceuticals Inc. (ADMS) [hlAlert]

down 31.86 %

Adamas Pharmaceuticals Inc. (ADMS) rated Outperform with price target $37 by Credit Suisse

Posted on: Friday,  Dec 25, 2015  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Adamas Pharmaceuticals Inc. (NASDAQ: ADMS) on 12/25/2015. Previously Credit Suisse rated Outperform Adamas Pharmaceuticals Inc. (NASDAQ: ADMS) on
12/24/2015., when the stock price was $29.44. Since then, Adamas Pharmaceuticals Inc. has lost 31.86% as of 01/19/2016's recent price of $20.06.
If you would have followed the previous Credit Suisse's recommendation on ADMS, you would have lost 31.86% of your investment in 26 days.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/25/2015 8:25 AM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/24/2015 10:25 AM Buy
29.44 37.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy